论文部分内容阅读
本文报告了克癌临水煎液对小鼠移植性肝癌（Ｈ２２）的治疗作用。以该药２２７ｇ／ｋｇ·Ｗ灌服荷实体型肝癌（Ｈ２２）小鼠，能显著抑制其肿瘤生长，肿瘤抑制率达５１３％；并能明显抑制荷瘤机体肿瘤坏死因子（ＴＮＦ）水平的异常增高，使其维持在一定水平而发挥抗肿瘤、调节机体免疫力等作用。经流式细胞术检测，表明该药还可阻滞肿瘤细胞从细胞周期Ｇ１期向Ｓ期的转变过程，阻断ＤＮＡ合成和复制，并进一步诱发其发生较高水平的细胞凋亡。上述可能是克癌临治疗肝癌的重要机制
This article reports the therapeutic effect of decancer-side decoction on transplanted liver cancer (H22) in mice. The injection of 227g/kg·W of this drug into mice bearing solid-state H22 (H22) significantly inhibited the growth of the tumor, and the tumor inhibition rate was 51. 3%. It also significantly inhibited the tumor-bearing tumor necrosis factor (TNF). ) The level of abnormal increase, to maintain it at a certain level and play a role in anti-tumor, regulating the body’s immunity. Flow cytometry showed that the drug can also block the transition from G1 phase to S phase of the cell cycle, block DNA synthesis and replication, and further induce higher levels of apoptosis. The above may be an important mechanism for cancer treatment of liver cancer